Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
UCB-7853 by UCB for Parkinson's Disease: Likelihood of Approval
UCB-7853 is under clinical development by UCB and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...
Data Insights
Clenbuterol hydrochloride by CuraSen Therapeutics for Parkinson's Disease: Likelihood of Approval
Clenbuterol hydrochloride is under clinical development by CuraSen Therapeutics and currently in Phase II for Parkinson's Disease. According to GlobalData,...